|
1 |
Recent Update in Pharmacological Agents for Optic Pathway Glioma
Meerim Park
|
|
2 |
Rapamycin reduces orofacial nociceptive responses and microglial p38 mitogen-activated protein kinase phosphorylation in trigeminal nucleus caudalis in mouse orofacial formalin model
Ji-Hee Yeo, Sol-Ji Kim, Dae-Hyun Roh
|
|
3 |
Potentiation of the Anticancer Effects by Combining Docetaxel with Ku-0063794 against Triple-Negative Breast Cancer Cells
Ye-Won Jeon, Ok-Hee Kim, Jin Sun Shin, Ha Eun Hong, Cho Hee Kim, Say-June Kim
|
|
4 |
Mechanistic Target of Rapamycin Pathway in Epileptic Disorders
Jang Keun Kim, Jeong Ho Lee
|
|
5 |
NLRC3 Attenuates Colon Cancer by Down-Regulating PI3K-mTOR Signaling
Irshad Ali, Young-Sang Koh
|
|
6 |
Identification of Downstream Genes of the mTOR Pathway that Predict Recurrence and Progression in Non-Muscle Invasive High-Grade Urothelial Carcinoma of the Bladder
Subin Jin, In Ho Chang, Jin Wook Kim, Young Mi Whang, Ha Jeong Kim, Soon Auck Hong, Tae-Jin Lee
|
|
7 |
Oleanolic acid induced autophagic cell death in hepatocellular carcinoma cells via PI3K/Akt/mTOR and ROS-dependent pathway
Yang Shi, Qingwei Song, Dianhe Hu, Xiaohu Zhuang, Shengcai Yu, Dacai Teng
|
|
8 |
Dual-Blocking of PI3K and mTOR Improves Chemotherapeutic Effects on SW620 Human Colorectal Cancer Stem Cells by Inducing Differentiation
Min-Jung Kim, Jeong-Eun Koo, Gi-Yeon Han, Buyun Kim, Yoo-Sun Lee, Chiyoung Ahn, Chan-Wha Kim
|
|
9 |
P70S6K and Elf4E Dual Inhibition Is Essential to Control Bladder Tumor Growth and Progression in Orthotopic Mouse Non-muscle Invasive Bladder Tumor Model
Byung Hoon Chi, Soon-Ja Kim, Ho Kyung Seo, Hye-Hyun Seo, Sang-Jin Lee, Jong Kyou Kwon, Tae-Jin Lee, In Ho Chang
|
|
10 |
Establishment of an Orthotopic Mouse Non-Muscle Invasive Bladder Cancer Model Expressing the Mammalian Target of Rapamycin Signaling Pathway
Soon-Ja Kim, Ho Kyung Seo, Hye-Hyun Seo, Sang-Jin Lee, Jong Kyou Kwon, Tae-Jin Lee, Byung Hoon Chi, In Ho Chang
|
|
11 |
Increased Phosphorylation of PI3K/Akt/mTOR in the Obstructed Kidney of Rats with Unilateral Ureteral Obstruction
Seong Kwon Ma, Soo Yeon Joo, Chang Seong Kim, Joon Seok Choi, Eun Hui Bae, JongUn Lee, Soo Wan Kim
Chonnam Med J.2013;49(3):108-112. Published online 2013 December 23
DOI: http://dx.doi.org/10.4068/cmj.2013.49.3.108
|
|
12 |
Regulation of paclitaxel-induced programmed cell death by autophagic induction: A model for cervical cancer
Eun Young Chi, Boonlert Viriyapak, Hyun Sung Kwack, Yoon Kyung Lee, Sang Il Kim, Keun Ho Lee, Tae Churl Park
|
|
13 |
Rapamycin Inhibits Transforming Growth Factor β1-Induced Fibrogenesis in Primary Human Lung Fibroblasts
Yu Gao, Xuefeng Xu, Ke Ding, Yan Liang, Dianhua Jiang, Huaping Dai
Yonsei Med J.2013;54(2):437-444. Published online 2013 January 22
DOI: http://dx.doi.org/10.3349/ymj.2013.54.2.437
|
|
14 |
Induction of Melanogenesis by Rapamycin in Human MNT-1 Melanoma Cells
Young-Sool Hah, Hee Young Cho, Tae-Yeon Lim, Dong Hwa Park, Hwa Mi Kim, Jimi Yoon, Jin Gu Kim, Chi Yeon Kim, Tae-Jin Yoon
Ann Dermatol.2012;24(2):151-157. Published online 2012 April 26
DOI: http://dx.doi.org/10.5021/ad.2012.24.2.151
|
|
15 |
Current Status of Targeted Therapy for Advanced Renal Cell Carcinoma
In-Chang Cho, Jinsoo Chung
|
|
16 |
Treatment strategies for Hodgkin lymphoma recurring following autologous hematopoietic stem cell transplantation
Erin-Siobhain R. Currin, Ajay K. Gopal
|
|
17 |
Role of the mTOR Pathway in the Progression and Recurrence of Bladder Cancer: An Immunohistochemical Tissue Microarray Study
Se Jun Park, Tae Jin Lee, In Ho Chang
|
|
18 |
Phosphorylated Akt and Phosphorylated mTOR Expression in Breast Invasive Carcinomas: Analysis of 530 Cases
Jungsuk An, Hoiseon Jeong, Youngseok Lee, Sang Uk Woo, Jae Hong Seo, Aeree Kim
J Breast Cancer.2010;13(4):337-348. Published online 2010 December 31
DOI: http://dx.doi.org/10.4048/jbc.2010.13.4.337
|
|
19 |
High expression of mTOR is associated with radiation resistance in cervical cancer
Min-Kyu Kim, Tae-Joong Kim, Chang Ok Sung, Chel Hun Choi, Jeong-Won Lee, Byoung-Gie Kim, Duk-Soo Bae
J Gynecol Oncol.2010;21(3):181-185. Published online 2010 September 28
DOI: http://dx.doi.org/10.3802/jgo.2010.21.3.181
|
|
20 |
Malignancy in Renal Transplant Recipients
Jin Min Kong
|
|